Skip to content

Dr. E. Voets

Active Private limited companyfounded 2020active for 6 yearsKattenberg 125, 2460 KasterleeKBO/BCE: BE 0741.573.413 #10 company by total assets in Kasterlee, Health and social work sector
Dr. E. Voets
Follow ReportCompare

Overview

Lifetime

6 annual accounts with figures on one time axis
peak €562,457 (2025)
€562,457▲ 29.8%
peak €255,516 (2020)
€206,577▲ 96.1%
peak €504,671 (2022)
€504,671unchanged
€772,007▼ 0.2%
Board1 name since 2021
1 directorVoets Evy
Documentsfilings and deeds
03-06-202658 days before the deadline
2025micro format
Gross margin from €433,453 to €562,457Result from €105,325 to €206,577Dividend €206,577Cash from €304,895 to €740,623

Key points

from the 2025 annual accounts

Equity

€504,671 =
504,6712024+206,577Profit-206,577Dividend504,6712025

Dr. E. Voets paid out €206,577 in dividends. That is 100% of the 2025 profit.

Result

€206,577 ▲ 96.1%
€105,0002024€207,0002025

The result rose in 2025 from €105,325 to €206,577.

Turnover

≈ €850,000 estimated

The micro format states no turnover.

Investments

€13,014 0.1 × depreciation
2021202220242025

Green is investment, beige is depreciation.

Filings

6 annual accounts since 2020
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 6 to 58 days before the end of the period.

Position in the sector

€206,577

Higher net result than 88% of companies in human health. Sector median €60,070 · 20,754 companies.

Checked score

93
Excellent
Financially stronger than 48% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value

Financial strength
Strong

65+1equity 39.5% of total assets
93+14short-term debt 21.2% · cash 58.0%
89+10return on assets 16.2%

Score breakdown

lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €1.3m
Liquidity: current ratio 3.50, cash €740,623
Figures for financial year 2025 (filed on 04-06-2026)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 32% of them on solvency, 79% on liquidity, 43% on profitability and 37% on growth.

The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 6,782 companies had the same profile as Dr. E. Voets has now. Each dot stands for 17 companies, two years later.

96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of Dr. E. Voets itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,782 companies, not a prediction for Dr. E. Voets. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €45,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 3.5 (4.73 in 2024), above the usual 1.5. Short-term debt is 21.2% and cash 58% of total assets. However, 60.5% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

5 signals, none raises the risk
Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €1.3m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 3.50, cash €740,623
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 04-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
58 days early
2024
34 days early
2023
44 days early
2022
28 days early
2021
6 days early
2020
43 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 36 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

VE
Voets Evy
Director
  • Evy Voets founderdeed of 17-01-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0741573413
Incorporation Founder: Evy Voets · published on 17-01-2020 · Gazette deed
First establishment Kattenberg 125, Kasterlee
All 12 events

Comparable companies

same main activity, similar in size and age
Company
Dr. E. Voets Kasterlee €1.3m €562,457 39.5% -
Dr. Benjamin Peters Schilde €1.2m €522,224 87.7% -
Soscia GL Mons €1.4m €549,650 75.0% -
DR. RUBEN DE GROOTE – UROLOOG Sint-Martens-Latem €1.5m €547,377 99.1% -
Dr. Sven Adam – Urgentie- en sportgeneeskunde Haaltert €1.3m €499,602 73.1% -
Dokter Nele Myngheer, Endocrino-diabetologie Kortrijk €1.2m €502,349 5.2% -
Dr. Karolien Theuwis Putte €1.2m €624,722 29.3% -

These companies have the same main activity as Dr. E. Voets: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.2m and €1.5m, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 15-01-2020Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.298.495.0732460 Kasterlee, since 15-01-2020
Financial year end
31 December
Peppol
Reachable since 05-03-2025
Company details

Annual accounts 2025

€562,457▲ 29.8%
€206,577▲ 96.1%
€504,671=
€1.3m▼ 0.1%
Filing
Filed on 03-06-2026, 58 days before the end of the filing period
Financials

Insights on Dr. E. Voets

Dr. E. Voets files the micro format. That format states no turnover. The gross margin rose from €548,883 in 2020 to €562,457 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 03-06-2026, 58 days before the deadline
€562,457
▲ 29.8%
€322,101
▲ 69.1%
€206,577
▲ 96.1%
€677,790
▲ 18.3%
39.5%
unchanged
3.50
▼ 1.23

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €850,000. Estimated: probably between €760,000 and €1.2m.

In the rankings #10 company by total assets in Kasterlee, Health and social work sector

Balance sheet

balance sheet total €1.3m on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

39.5%

Higher than 32% of 20,767 companies in 2025.

3.50

Higher than 58% of 20,341 companies in 2025.

16.2%

Higher than 40% of 20,623 companies in 2025.

Dr. E. Voets Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: top quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023202220212020
Balance sheet: assets
20/58 1.3m1.3m1.3m1.4m1.6m1.7m
21/28 328,131551,865653,508861,546944,6461.1m
21 189,493373,065556,636740,207923,7791.1m
22/27 138,638178,80096,873121,33920,8674,471
24 131,552168,82884,014105,5941,3322,664
26 7,0869,97212,85815,74519,5351,807
29/58 948,547726,160683,421526,417640,453578,538
3 ---1433,446-
30/36 ---1433,446-
40/41 -34,370---489
40 -495---489
41 -33,875----
50/53 -202,421----
54/58 740,623304,895478,333333,313504,804422,755
490/1 207,924184,474205,088192,961132,203155,294
Balance sheet: equity and liabilities
10/49 1.3m1.3m1.3m1.4m1.6m1.7m
10/15 504,671504,671504,671504,671330,538260,516
10/11 5,0005,0005,0005,0005,0005,000
13 499,671499,671499,671499,671325,538255,516
133 499,671499,671499,671499,671325,538255,516
17/49 772,007773,353832,259883,2921.3m1.4m
17 500,000585,000585,000760,0001.2m1.3m
178/9 500,000585,000585,000760,0001.2m1.3m
42/48 270,757153,451244,598111,28966,284128,594
44 2,1871,5392,4587322,5791,854
440/4 2,1871,5392,4587322,5791,854
45 31,56418,71268,593104,72958,562116,483
450/3 31,56418,16268,593104,72955,512113,433
454/9 -550--3,0503,050
47/48 237,006133,201173,5475,8275,14310,256
492/3 1,25034,9012,66112,0043,2771,250
Income statement
9900 562,457433,453484,045504,017346,708548,883
630 236,747228,745208,038190,999187,381179,885
640/8 3,60911,0794,18212,222838680
66A -3,100----
9901 322,101190,529271,825300,796158,489368,317
75/76B 5406,157-2--
75 5406,157-2--
65/66B 40,27348,38938,41739,69750,752244
65 40,27348,38938,41739,69750,752244
9903 282,368148,297233,408261,102107,738368,074
67/77 75,79142,97260,75186,96837,716112,558
9904 206,577105,325172,658174,13470,022255,516
9905 206,577105,325172,658174,13470,022255,516
Appropriation of the result
9906 206,577105,325172,658174,13470,022255,516
691/2 ---174,13470,022255,516
6921 ---174,13470,022255,516
694/7 206,577105,325172,658---
694 206,577105,325172,658---
Document PDFPDFPDFPDFPDFPDF

The notes to these accounts have 8 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 03-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 03-06-2026 2026-00136588 PDF
31-12-2024 micro format 27-06-2025 2025-00186612 PDF
31-12-2023 micro format 17-06-2024 2024-00132730 PDF
31-12-2022 micro format 03-07-2023 2023-00188159 PDF
31-12-2021 micro format 25-07-2022 2022-20215864 PDF
31-12-2020 micro format 18-06-2021 2021-21000097 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023202220212020
558,848419,274479,863491,796345,870548,203
443,324334,070380,695365,133257,403435,401
13,014127,1010107,90020,2051.3m
435,729-173,438145,020-171,49182,049-
677,790572,708438,823415,129574,169449,944
39.5%39.5%37.7%36.4%20.9%15.4%
3.504.732.794.739.664.50
3.504.732.794.739.614.50
1.531.531.651.753.805.49
40.9%20.9%34.2%34.5%21.2%98.1%
16.2%8.2%12.9%12.5%4.4%15.1%
13.888.6612.4912.396.81-

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€13,014€127,101-€107,900€20,205
€236,747€228,745€208,038€190,999€187,381

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on Dr. E. Voets

The operating result for 2025 is 69% higher than in 2024 and the highest since 2020. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total stays at 60.5%.

Board & ownership

Board

1 director
Voets Evy
Director
listed in the 2025 annual accounts, filed on 03-06-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
Voets Evy
Director
Boardmandate already running before its first mention
Mandates as a list
  • Voets Evy
    • Director, since before 31-12-2021

See the board, name and registered office on a given date →

Control

Founder
Evy Voets
This company
Dr. E. Voets
Equity €504,671
Profit €206,577 in 2025

Capital

Contribution
€5,000
Source
2025 annual accounts

Articles of association

deed of 17-01-2020 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Thursday of June at 17:00

Founder

At incorporation deed of 17-01-2020 ↗
  • Evy Voets sole founder · 100% at incorporation

Network & group

No group

Dr. E. Voets has no parent and no holdings in its annual accounts. Voets Evy is the only director.

At the same address

Kattenberg 125, 2460 Kasterlee · 2 other companies
DOKTER MOLDEREZ C.
registered office since 05-12-2001 · founded in 2001
 total assets €2.0m (2025)
0476.252.281
Mcee beheer
registered office since 29-09-2009 · founded in 2009
 total assets €1.2m (2025)
0819.153.122

Board mandates elsewhere

1 board mandate
Board mandates of Dr. E. VoetsDr. E. Voets sits on their board1
SPECIALISTENVERENIGING ZUID OOST KEMPEN GEEL
Director
Founded in 2023

Connections & network

1 current director
Depth

The board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Timeline

12 events since 2020

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed PDFmicro format · 58 days before the deadline
2025
Annual accounts 2024 filed PDFmicro format · 34 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0741573413
2024
Annual accounts 2023 filed PDFmicro format · 44 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 28 days before the deadline
2022
Equity above €500,000 equity €504,671 ▲52.7% With a profit in every financial year since 2020, equity grows to €504,671.
Annual accounts 2021 filed PDFmicro format · 6 days before the deadline
2021
Weakest financial year net €70,022 ▼72.6% The net result drops to €70,022, the lowest from 2020 to 2025. It recovers the following year.
Liquidity more than doubled current ratio 9.66 The current ratio rises from 4.50 to 9.66. Short-term debt falls from €128,594 to €66,284.
Annual accounts 2020 filed PDFmicro format · 43 days before the deadline
2020
IncorporationFounder: Evy Voets · published on 17-01-20201 point ▸
  • Founder, Evy Voets

Open the deed in the Belgian Official Gazette

First establishment Kattenberg 125, Kasterlee

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

Dr. E. Voets was incorporated on 15 January 2020 as a private limited company by one natural person.12 Voets Evy is director of the company according to the 2025 annual accounts.3 Total assets fell from €1.7m in 2020 to €1.3m in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 17-01-2020
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2020 and 2025

Company details

Identity

Enterprise number
0741.573.413
VAT number
BE 0741.573.413
Peppol ID
0208:0741573413
Other Peppol ID
9925:BE0741573413
Legal form
Private limited company
Status
Active, normal situation
Founded
15-01-2020
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Thursday of June at 17:00
deed of 17-01-2020 (in Dutch)
Peppol
Reachable since 05-03-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
Dr. E. Voets in Dutch
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 17-01-2020 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 17-01-2020 (in Dutch)

Activities

NACEBEL 2025
86220 Specialist medical practice main activity
Codes under NACEBEL 2008
86220 Human health activities main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“Het toestaan van leningen en kredietopeningen aan rechtspersonen en ondernemingen of particulieren,onder om het even welke vorm; in dit…”
22 activities
  1. Het toestaan van leningen en kredietopeningen aan rechtspersonen en ondernemingen of particulieren,onder om het even welke vorm; in dit kader kan zij zich borg stellen of haar aval verlenen,in de meest ruime zin,alle handels- en financiële operaties verrichten behalve die wettelijk voorbehouden zijn aan depositokassen,houders van deposito’s op korte termijn,spaarkassen,hypotheekmaatschappijen en kapitalisatieondernemingen.
  2. De aandeelhouder(s) zullen steeds de bepalingen van Geneeskundige Plichtenleer van de Orde van artsen naleven zodanig dat overeenkomsten die artsen niet mogen afsluiten met andere artsen of derden,ook door de vennootschap niet zullen mogen worden afgesloten.
  3. De arts-aandeelhouder(s) dienen hun volledige medische activiteit uit te oefenen binnen het kader van de vennootschap.
  4. Elke arts-aandeelhouder moet de andere aandeelhouders inlichten over elke opgelopen disciplinaire,correctionele of administratieve veroordeling met weerslag op de gemeenschappelijke beroepsuitoefening.
  5. De uitoefening van de geneeskunde in het algemeen door de arts-aandeelhouder(s) in naam en voor rekening van de vennootschap,en rekening houdend met de bepalingen van geneeskundige plichtenleer.
  6. De uitoefening van de geneeskunde als specialist met discipline anesthesie en intensieve zorgen door de arts-aandeelhouder(s) in naam en voor rekening van de vennootschap,en rekening houdend met de bepalingen van geneeskundige plichtenleer.
  7. De geneeskunde wordt uitgeoefend door artsen onder de specifieke aansprakelijkheid van de aandeelhouder(s) en de bijkomende aansprakelijkheid van de vennootschap.
  8. De activiteit omvat impliciet de inning van de erelonen door en voor de vennootschap en de betaling aan de arts-aandeelhouder(s) van een vergoeding in verhouding tot de prestatie die hij/zij voor rekening van de vennootschap geleverd heeft
  9. De vennootschap mag alle verrichtingen stellen van onroerende,roerende of financiële aard die rechtstreeks of onrechtstreeks met haar doel verwant of verknocht zijn of de verwezenlijking ervan kunnen bevorderen.
  10. Verhuring van divers materieel.
  11. Aankopen,vervreemden,huren,verhuren of terbeschikkingstelling aan leden van het personeel of van organen van bestuur van zakelijke rechten.
  12. Het ter beschikking stellen van alle nodige middelen aan de arts/artsen die tot de vennootschap zijn toegetreden waaronder doch niet uitsluitend: het inrichten van de praktijk voor de geneeskunde; de uitvoering van technische,medische,radiografische en laboratoriumprestaties,
  13. Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder,die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten;
  14. De aankoop,het huren of leasen van alle medische apparatuur en begeleidende accommodatie voor voornoemde activiteiten,
  15. Het aanleggen van reserves teneinde alle nodige apparaten en gebouwen aan te schaffen,nodig of nuttig om voormeld doel te bereiken;
  16. De mogelijkheid scheppen om de arts-aandeelhouder(s) toe te laten zich verder te bekwamen ten einde in hun discipline aan de spits van de evolutie te blijven.
  17. Zij kan ook functies van bestuurder en vereffenaar van andere vennootschappen uitoefenen.
  18. Zij mag zich borg stellen of aval verlenen,voorschotten en krediet toestaan,hypothecaire of andere waarborgen verstrekken.
  19. Het aanleggen,het oordeelkundig uitbouwen en beheren van een roerend patrimonium,alle verrichtingen met betrekking tot roerende goederen en rechten,van welke aard ook; het beleggen,het intekenen op,vast overnemen,plaatsen,kopen,verkopen en verhandelen van aandelen,deelbewijzen,obligaties,warrants,certificaten,schuldvorderingen,gelden en andere roerende waarden,uitgegeven door Belgische of buitenlandse ondernemingen al dan niet onder de vorm van handelsvennootschappen,administratiekantoren,instellingen en verenigingen al dan niet met een (semi)-publiekrechtelijk statuut.
  20. Het aanleggen,het oordeelkundig uitbouwen en beheren van een onroerend vermogen,alle verrichtingen met betrekking tot onroerende goederen en onroerende zakelijke rechten zoals de huurfinanciering van onroerende goederen aan derden,het aankopen,verkopen,ruilen,bouwen,verbouwen,onderhouden,verhuren,huren,verkavelen,prospecteren en uitbaten van onroerende goederen; De aan- en verkoop,huur en verhuur van onroerende goederen,alsmede alle handelingen die rechtstreeks of onrechtstreeks met dit doel in verband staan en die van aard zijn de opbrengst van de onroerende goederen te bevorderen,alsmede zich borg te stellen voor het goede verloop van verbintenissen door derde personen aangegaan die het genot zouden hebben van de onroerende goederen.
  21. Het beheren van beleggingen en van participaties in dochtervennootschappen,het waarnemen van bestuurdersfuncties,het verlenen van advies,management en andere diensten aan of in overeenstemming met de activiteiten die de vennootschap zelf voert. Deze diensten kunnen worden geleverd krachtens contractuele of statutaire benoemingen en in de hoedanigheid van externe raadgever of orgaan van de cliënt.
  22. Het waarnemen van alle bestuurdersfuncties,beheersmandaten en vervullen van statutaire opdrachten/mandaten,zoals de uitoefening van de functies van bestuurder,gedelegeerd bestuurder en vereffenaar van vennootschappen.
deed of 17-01-2020 (in Dutch)

Registered office and establishments

1 establishment
Establishment Since Unit number
Kattenberg 125 registered office 2460 Kasterlee 15-01-2020 2.298.495.073

Buildings and parcels at the address

Ground area
2,039 m²
Buildings
210 m²
Volume, LiDAR
1,820 m³
Tallest building
12.1 m
Buildings to scale, each on its own parcel
210 m², 12.1 m 210 m², 12.1 m

Location

registered office establishment The establishment unit on the map
3 companies at this address See who is registered here

Parcels

Cadastral parcelArea Buildings Height / floors
13017G0019/00L0002,039 m² 1 · 210 m² 12.1 m · 3

We would like to set cookies. That happens only with your consent. What we measure